Phase I Study of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors
Status:
Completed
Trial end date:
2015-10-14
Target enrollment:
Participant gender:
Summary
This is a two part phase I study in Japanese patients that will determine the safety,
tolerability and pharmacokinetics of pazopanib monotherapy and of pazopanib in combination
with lapatinib.